HOTH Stock Analysis: Buy, Sell, or Hold?
HOTH - Hoth Therapeutics, Inc. Common Stock
$0.89
-0.03 (-2.93%)
▼
5d:
-16.21%
30d:
-11.18%
90d:
-36.56%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When HOTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called HOTH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HOTH is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HOTH is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HOTH is currently trading at $0.89, which is considered oversold relative to its 30-day fair value range of $0.98 to $1.08.
Technical Outlook: Technically, HOTH is in a strong downtrend. The price is currently testing key support at $0.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+462.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HOTH is in a strong downtrend. The price is currently testing key support at $0.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+462.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.98 -
$1.08
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 462.9% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -16.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.98 -
$1.08
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.87
Resistance Level
$1.13
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.07
Wall Street Target
$5.00
(+462.9%)
Last updated: February 01, 2026 10:51 PM ET
Data refreshes hourly during market hours. Next update: 11:51 PM
Data refreshes hourly during market hours. Next update: 11:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HOTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
